Crizalk 250 mg Tablets

Manufacturer: Pfizer Ltd

Medicine composition: Crizotinib

Crizalk 250Mg Capsule is a cancer fighting agent a part of the chemotherapy procedures. It treats malignant tumours both in adults and children. It is effective in the treatment of non-small cell lung carcinoma, which is a type of lung cancer. It attempts to inhibit the spread of cancer cells or malignant tumours to other parts of the body.